Viscofan reaches preliminary agreement to acquire up to 85% of Shandong Haiaos

• Viscofan reached a preliminary agreement to acquire up to 85% of Chinese collagen casings producer Shandong Haiaos Biotechnology.
• Pricing is based on an enterprise value of RMB 1 billion (EUR 133 million), adjusted for net debt and working capital.
• Closing is expected in the first quarter of 2027, subject to acquiring at least 80%, definitive agreements and other conditions.
• Founders will temporarily retain 15%, with acquisition of that stake planned for the third anniversary of closing.
• The purchase will use internal resources and local financing, without materially affecting the buyer’s financial position or shareholder remuneration policy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viscofan SA published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.